Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1997-6-19
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/D13942, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/J02227, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/J02288, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/J02400, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K02449, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/M20322, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/M20775, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/M35834, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/M57473, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21836, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21837, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21838, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21839, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21840, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21841, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21842, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21843, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U21844, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U73178, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U73500, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/V01108, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/X02449
pubmed:abstractText
The central demyelinating disease progressive multifocal leukoencephalopathy (PML) is caused by the human polyomavirus JC virus (JCV). JCV evolved as geographically based genotypes of which Type 3 is an African variant first characterized in HIV-1 positive patients from Tanzania. This study reports the complete sequence of five JCV Type 3 strains. The entire JCV genome was PCR amplified from urine specimens of three African and two African-American individuals. The African consensus sequence was compared to the Type 1 and Type 2 prototype strains, JCV (Mad-1) and JCV(GS/B), respectively. Type 3 differed in 2.2% of its coding region genome from JCV (Mad-1) and in 1.3% from JCV(GS/B). Within the coding region the sequence variation among the three types was higher in the capsid protein VP1 and in the regulatory protein large T antigen than in the agnoprotein or in VP2/3. Notable Type 3-specific changes were located at sites adjacent to the zinc finger motif and near the major donor and acceptor splice junctions of large T antigen. Four of the five urinary Type 3 strains had an unrearranged, archetypal regulatory region. African strain #309 showed a 10-bp deletion at a location similar to that previously described for #307 from Tanzania. The African-American Type 3 strain #312 was closely related to the African consensus sequence. The complete genome of a urinary JCV strain from another African-American male, previously reported as a possible Type 5, showed a sequence difference of only 0.52% from the Tanzanian consensus and has been reclassified as a subtype of Type 3.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0304-8608
pubmed:author
pubmed:issnType
Print
pubmed:volume
142
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
637-55
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Five complete genomes of JC virus type 3 from Africans and African Americans.
pubmed:affiliation
Laboratory of Experimental Neuropathology, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't